
Keywords: AUDPC; area under disease progression curve; BABA; β-aminobutyric acid; BTH; benzothiadiazole; DAMP; damage associated molecular pattern; DMSO; dimethyl sulfoxide; PR; pathogenesis-related; PTI; PAMP triggered immunity; PVPP; polyvinylpolypyrrolidone; RN